News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
23,449 Results
Type
Article (1238)
Company Profile (3)
Press Release (22208)
Section
Business (10956)
Career Advice (15)
Deals (1468)
Drug Development (2474)
FDA (421)
Job Trends (678)
News (14585)
Policy (859)
Tag
2027 Pharm Country Standard (1)
Academia (19)
Allergies (4)
Alliances (904)
ALS (8)
Alzheimer's disease (32)
Antibody-drug conjugate (ADC) (3)
Approvals (444)
Artificial intelligence (7)
Autoimmune disease (1)
Automation (1)
Bankruptcy (13)
Best Places to Work (609)
Biosimilars (3)
Biotechnology (1)
Bladder cancer (11)
Breast cancer (22)
Cancer (124)
Cardiovascular disease (9)
Career advice (16)
CAR-T (1)
Cell therapy (3)
Cervical cancer (3)
Clinical research (2165)
Collaboration (20)
Compensation (67)
COVID-19 (154)
CRISPR (4)
C-suite (3)
Cystic fibrosis (8)
Data (179)
Denatured (3)
Depression (2)
Diabetes (8)
Diagnostics (215)
Digital health (2)
Drug discovery (1)
Drug pricing (2)
Duchenne muscular dystrophy (2)
Earnings (10291)
Events (2479)
Executive appointments (2)
FDA (595)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (2)
Funding (10)
Gene editing (5)
Gene therapy (6)
GLP-1 (28)
Government (123)
Guidances (125)
Healthcare (548)
HIV (3)
IgA nephropathy (1)
Immunology and inflammation (3)
Indications (4)
Infectious disease (157)
Inflammatory bowel disease (4)
Influenza (1)
Intellectual property (3)
Interviews (2)
IPO (1106)
Job creations (121)
Job search strategy (15)
Kidney cancer (2)
Labor market (1)
Layoffs (3)
Leadership (1)
Legal (126)
Lung cancer (23)
Lymphoma (7)
Manufacturing (11)
MASH (5)
Medical device (527)
Medtech (530)
Mergers & acquisitions (361)
Metabolic disorders (25)
Multiple sclerosis (5)
NASH (1)
Neurodegenerative disease (3)
Neuropsychiatric disorders (2)
Neuroscience (60)
NextGen: Class of 2026 (170)
Non-profit (37)
Obesity (13)
Opinion (1)
Ovarian cancer (4)
Pain (4)
Pancreatic cancer (6)
Parkinson's disease (3)
Patents (5)
Patient recruitment (3)
Peanut (3)
People (680)
Pharmaceutical (2)
Pharmacy benefit managers (1)
Phase 1 (550)
Phase 2 (852)
Phase 3 (967)
Pipeline (500)
Policy (1)
Postmarket research (88)
Preclinical (166)
Prostate cancer (3)
Radiopharmaceuticals (4)
Rare diseases (20)
Real estate (143)
Regulatory (674)
Reports (1)
Research institute (35)
Rett syndrome (1)
Schizophrenia (3)
Series B (1)
Sickle cell disease (2)
Special edition (1)
Spinal muscular atrophy (1)
Startups (73)
Supply chain (1)
Vaccines (22)
Weight loss (9)
Women's health (2)
Date
Today (16)
Last 7 days (31)
Last 30 days (80)
Last 365 days (1275)
2026 (90)
2025 (1261)
2024 (1411)
2023 (1784)
2022 (1868)
2021 (1878)
2020 (1673)
2019 (1039)
2018 (830)
2017 (628)
2016 (6705)
2015 (561)
2014 (415)
2013 (226)
2012 (280)
2011 (357)
2010 (383)
Location
Africa (25)
Alabama (1)
Arizona (5)
Asia (1423)
Australia (200)
California (465)
Canada (107)
China (30)
Colorado (21)
Connecticut (21)
Delaware (19)
Europe (3444)
Florida (56)
Georgia (15)
Illinois (29)
India (1)
Indiana (23)
Japan (5)
Kansas (1)
Kentucky (4)
Louisiana (7)
Maine (6)
Maryland (59)
Massachusetts (305)
Michigan (10)
Minnesota (31)
Mississippi (2)
Missouri (4)
Nevada (2)
New Hampshire (3)
New Jersey (181)
New York (117)
North Carolina (57)
Northern California (289)
Ohio (4)
Pennsylvania (136)
Puerto Rico (3)
South America (36)
Southern California (140)
Tennessee (3)
Texas (53)
United States (1673)
Utah (21)
Virginia (7)
Washington State (31)
Wisconsin (6)
23,449 Results for "162".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Biologics Manufacturing Market Size to Hit USD 162.51 Billion by 2034, Growing at an Extraordinary 17.1% CAGR
November 20, 2025
·
1 min read
Press Releases
Obstructive Sleep Apnea Market Expected to Exhibit a CAGR of 16.2% During 2025-2035, Impelled by Advancements in Early Detection
February 14, 2025
·
12 min read
Press Releases
uniQure Announces Favorable Recommendation from Independent Data Monitoring Committee for its Phase I/II EPISOD1 Clinical Trial of AMT-162 for the Treatment of SOD1-ALS
January 30, 2025
·
5 min read
Policy
Lumen Bioscience awarded $16.2 million in DoD funding to advance LMN-201 through late-stage trials
Lumen Bioscience—a clinical-stage biotechnology company developing biologic drugs for highly prevalent diseases, announced it was awarded $16.2 million by the U.S. Department of Defense to advance LMN-201 through late-stage trials.
October 17, 2023
·
3 min read
Press Releases
uniQure Announces Dosing of First Patient in Phase I/II Clinical Trial of AMT-162 for the Treatment of SOD1-ALS
October 16, 2024
·
5 min read
Press Releases
uniQure Announces Dosing of First Patient in Phase I/II Clinical Trial of AMT-162 for the Treatment SOD1-ALS
October 15, 2024
·
5 min read
U.S. 3D Cell Culture Market Size Set to Soar USD 1.62 Bn by 2033
According to recent study by nova one advisor, the U.S. 3D cell culture market size was valued at USD 565.90 million in 2023...
May 8, 2024
·
9 min read
Global Smart Healthcare Market Growth Rate of 16.2 % over the Forecast Period [2020-2027]
The latest business intelligence studies predict that the global smart healthcare market will expand at a stellar compound annual growth rate of 16.2 % over the forecast period of 2020 to 2027.
May 19, 2022
·
8 min read
Orthodontics Market Size to Worth Around US$ 16.2 BN by 2028
The global orthodontics market size is predicted to be worth around US$ 16.2 billion by 2028 from valued at US$ 5.99 billion in 2021, growing at a CAGR of 15.3% from 2021 to 2030.
March 11, 2022
·
4 min read
Nutrigenomics Market Size to Reach USD 1,289.7 Million in 2028 Growing at a CAGR of 16.2%, according to Emergen Research
According to Emergen Research, the global nutrigenomics market size was USD 389.4 Million in 2020 and is expected to reach USD 1,289.7 Million in 2028 and register a revenue CAGR of 16.2% during the forecast period, 2021-2028.
December 8, 2021
·
6 min read
1 of 2,345
Next
